These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35005865)

  • 41. Self-perception of natural outcome, appearance, and emotional well-being after OnabotulinumtoxinA treatment for upper facial lines: Post hoc analysis across age and gender.
    Dayan S; Ogilvie P; Boyd C; De Boulle K; Cavallini M; Garcia JK; Musumeci M
    J Cosmet Dermatol; 2024 Jan; 23(1):107-116. PubMed ID: 37616390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face.
    de Maio M; Wu WTL; Goodman GJ; Monheit G;
    Plast Reconstr Surg; 2017 Sep; 140(3):393e-404e. PubMed ID: 28841604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin A and/or soft tissue fillers for facial rehabilitation.
    Wollina U; Goldman A
    Wien Med Wochenschr; 2017 Mar; 167(3-4):92-95. PubMed ID: 27631872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Use of Botulinum Toxin and Dermal Fillers to Enhance Patients' Perceived Attractiveness: Implications for the Future of Aesthetic Dentistry.
    Tran Cao P
    Dent Clin North Am; 2020 Oct; 64(4):659-668. PubMed ID: 32888515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superficial Dermal Fillers with Hyaluronic Acid.
    Bacos JT; Dayan SH
    Facial Plast Surg; 2019 Jun; 35(3):219-223. PubMed ID: 31189193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cohesive Polydensified Matrix Hyaluronic Acid for the Treatment of Etched-In Fine Facial Lines: A 6-Month, Open-Label Clinical Trial.
    Black JM; Gross TM; Murcia CL; Jones DH
    Dermatol Surg; 2018 Jul; 44(7):1002-1011. PubMed ID: 29315149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler.
    Pavicic T; Few JW; Huber-Vorländer J
    J Drugs Dermatol; 2013 Sep; 12(9):978-84. PubMed ID: 24002143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing the Complications Associated with the Use of Dermal Fillers in Facial Aesthetic Procedures: An Expert Group Consensus Report.
    Urdiales-Gálvez F; Delgado NE; Figueiredo V; Lajo-Plaza JV; Mira M; Ortíz-Martí F; Del Rio-Reyes R; Romero-Álvarez N; Del Cueto SR; Segurado MA; Rebenaque CV
    Aesthetic Plast Surg; 2017 Jun; 41(3):667-677. PubMed ID: 28411354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and durability of hyaluronic acid fillers for malar enhancement: A prospective, randomized, split-face clinical controlled trial.
    Jeong KH; Gwak MJ; Moon SK; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2018 Jun; 20(3):184-188. PubMed ID: 28135883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An optimal approach for facial rejuvenation: AbobotulinumtoxinA And small-particle hyaluronic acid.
    Sato MS; Romiti A; Gabay MA
    J Cosmet Dermatol; 2022 Nov; 21(11):6533-6535. PubMed ID: 35575902
    [No Abstract]   [Full Text] [Related]  

  • 52. Improvement of Radial Cheek Lines With Hyaluronic Acid-Based Dermal Filler VYC-17.5L: Results of the BEAM Study.
    Ogilvie P; Fink B; Leys C; Lipko-Godlewska S; Niforos F; Kelly R; Kerson G; Silberberg M
    Dermatol Surg; 2020 Mar; 46(3):376-385. PubMed ID: 31449079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Multicenter, Single-Blind Randomized, Controlled Study of a Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: Patient-Reported Outcomes at 2 Years.
    Few J; Cox SE; Paradkar-Mitragotri D; Murphy DK
    Aesthet Surg J; 2015 Jul; 35(5):589-99. PubMed ID: 25964628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injectable treatments for the aging face.
    Wise JB; Greco T
    Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facial rejuvenation starts in the midface: three-dimensional volumetric facial rejuvenation has beneficial effects on nontreated neighboring esthetic units.
    Wollina U
    J Cosmet Dermatol; 2016 Mar; 15(1):82-8. PubMed ID: 26304759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Open Label Study Evaluating Efficacy, Safety, and Effects on Perception of Age After Injectable 20 mg/mL Hyaluronic Acid Gel for Volumization of Facial Temples.
    Baumann LS; Weisberg EM; Mayans M; Arcuri E
    J Drugs Dermatol; 2019 Jan; 18(1):67-74. PubMed ID: 30681799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Providing Optimal Rejuvenation to the Jawline and Perioral Area Using Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2021 Oct-Dec 01; 41(4):225-231. PubMed ID: 34871290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction of Age-Related Midface Volume Loss With Low-Volume Hyaluronic Acid Filler.
    Wilson MV; Fabi SG; Greene R
    JAMA Facial Plast Surg; 2017 Mar; 19(2):88-93. PubMed ID: 27768196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging well--the role of minimally invasive aesthetic dermatological procedures in women over 65.
    Wollina U; Payne CR
    J Cosmet Dermatol; 2010 Mar; 9(1):50-8. PubMed ID: 20367673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.